http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0692980-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14cd6c48cd06a3a23f52c1940ff2b81f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2123-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F13-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57536
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
filingDate 1994-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c6a8155352e9d28b74b954bba799d38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44cd48aab6333ab73b3f8a7e458180bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d5f0f424b4d0840a333fb5aa6df5447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d378f51fa74ca983614fb4c9bf8a68d1
publicationDate 1999-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0692980-B1
titleOfInvention Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
abstract PCT No. PCT/DE94/00370 Sec. 371 Date Mar. 8, 1996 Sec. 102(e) Date Mar. 8, 1996 PCT Filed Mar. 29, 1994 PCT Pub. No. WO94/22492 PCT Pub. Date Oct. 13, 1994This invention relates to new bifunctional chelating agents with intermittent chalcogen atoms, pharmaceuticals containing these compounds, their use in radiodiagnostics and radiotherapy, and methods for the production of these compounds. The compound according to the invention has the general formula (I) M-L wherein M represents a radionuclide of Tc or Re and L a ligand of the general formula (II) B-CO-CR1R2-A-CR3R4-CO-D(II) These new, bifunctional chelating agents with intermittent chalcogen atoms and their coupling products with compounds that accumulate specifically are suited for producing radiopharmaceuticals for diagnostic and therapeutic purposes.
priorityDate 1993-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54253326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23212930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233577298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86754565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129769283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4478780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128151852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233905638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226455967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128657535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226502497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127448380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3083785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135812317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127552759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18373001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129092467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6451891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128388789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128577807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21613061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127763257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227034763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11718

Total number of triples: 71.